NYSE - Nasdaq Real Time Price USD

CVS Health Corporation (CVS)

Time to buy CVS?

66.78

+0.55

+(0.83%)

At close: 4:00:02 PM EDT

66.64

-0.14

(-0.21%)

After hours: 6:12:20 PM EDT

Time to buy CVS?

3 major takeaways from Novo Nordisk's Q1 earnings

Novo Nordisk (NVO) topped first quarter earnings estimates while its revenue figures came in line with analyst expectations Yahoo Finance senior health reporter Anjalee Khemlani joins the Catlaysts team to share the biggest takeaways from the pharmaceutical giant's earnings, including its global position in the GLP-1 weight-loss drug space and its partnership with CVS Health (CVS). Catch Anjalee Khemlani's full interview with Novo Nordisk CEO Lars Jørgensen. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.

Yahoo Finance Video 4 hours ago

CVS
+0.83%

NONOF

NVO
Jim Cramer on CVS Health Corporation (CVS): ‘David Joyner’s Stunning Turnaround Continues’

We recently published a list of Jim Cramer Reveals Trump’s Potential Secret Weapon In China Trade Talks & Discusses These 10 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on […]

Insider Monkey 4 hours ago

CVS
+0.83%
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised

COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.

Zacks 5 hours ago

CVS
+0.83%
AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.

Zacks 5 hours ago

AVNS

ITGR

BSX
FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y

Fresenius Medical's first-quarter results showcase a strong segmental performance, along with reiterating its 2025 outlook for revenue growth.

Zacks 5 hours ago

FME.DE

ITGR

CVS
+0.83%
CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y

Clover Health's first-quarter 2025 results continue to benefit from the strength of its strong member retention. A decline in operating loss bodes well.

Zacks 5 hours ago

ITGR

BSX

CVS
+0.83%
MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand

Masimo's first-quarter 2025 results continue to benefit from the strength in its Healthcare businesses despite tariff-related uncertainties.

Zacks 5 hours ago

MASI

BSX

ITGR
Top-Performing Stock: CVS Health Raises Outlook After Strong Earnings Beat

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Investor's Business Daily 8 hours ago

CVS
+0.83%
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Simply Wall St. 10 hours ago

CVS
+0.83%
Health insurers see signs of life in Q1

Payer profits fell in 2024 as Americans, especially older ones, utilized more medical care. But efforts to resuscitate margins appear to be working for most — at least for now, according to first quarter results.

Healthcare Dive 13 hours ago

UNH

CVS
+0.83%
Activist Glenview cuts stake in CVS after strong first-quarter earnings

CVS shares have generated a total return of 25% since it took a position last year, suggesting progress in the company's turnaround plan, the hedge fund said. It reduced its holdings by 3.75 million shares, just days after the healthcare conglomerate raised its annual forecast and beat Wall Street estimate for quarterly profit. CVS had been facing pressure from investors, including Glenview, to improve its operations and shareholder value after missing financial targets several times due to increased medical costs in its health insurance business.

Reuters yesterday

CVS
+0.83%
Glenview Capital Issues Statement on CVS Health

One year ago, we established a concentrated position in shares of CVS Health (NYSE: CVS). Since our purchases in May 2024, CVS shares have generated a total return of 25% reflecting initial progress in the long-term cultural and operational turnaround underway at the Company. Our position size afforded us the scale necessary to constructively engage with the Board, Management, and fellow Shareholders in Q3 2024 on a multi-faceted performance improvement plan:

PR Newswire yesterday

CVS
+0.83%
HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down

Hims & Hers' first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid product demand and an increasing subscriber base.

Zacks yesterday

ITGR

BSX

CVS
+0.83%
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts

Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.

Zacks yesterday

INSP

ITGR

CVS
+0.83%
What Makes CVS Health (CVS) a New Buy Stock

CVS Health (CVS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks yesterday

CVS
+0.83%
Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to pricing and access to its drug Zepbound emerged. The company's GLP-1 drugs continue to drive strong revenue growth. Mounjaro is approved by the Food and Drug Administration (FDA) to help adults with type 2 diabetes lower their blood glucose levels, while Zepbound is approved for weight loss in obese adults or overweight adults with at least one weight-related condition, such as high cholesterol or high blood pressure.

Motley Fool yesterday

LLY

CVS
+0.83%
Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Zacks yesterday

CVS
+0.83%
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks yesterday

CVS
+0.83%
CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025

We recently published a list of 11 Best Performing Large Cap Stocks So Far in 2025. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other best performing large cap stocks so far in 2025. The stock market had a chaotic start to the first quarter […]

Insider Monkey 2 days ago

CVS
+0.83%
With compounders out of the way, Lilly and Novo go after each other

The two obesity leaders are pulling on all levers to stay on top of the market.

Pharma Voice 2 days ago

LLY

CVS
+0.83%

NVO

Performance Overview

Return	CVS	S&P 500 (^GSPC)
YTD	+52.21%	-4.26%
1-Year	+25.34%	+8.55%
3-Year	-26.15%	+36.57%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

CVS Health Corporation (CVS)

3 major takeaways from Novo Nordisk's Q1 earnings

Jim Cramer on CVS Health Corporation (CVS): ‘David Joyner’s Stunning Turnaround Continues’

COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised

AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y

CLOV Stock Rises as Q1 Earnings Beat Estimates, Revenues Up Y/Y

MASI Stock Slips Despite Q1 Earnings and Revenue Beat, Margins Expand

Top-Performing Stock: CVS Health Raises Outlook After Strong Earnings Beat

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Health insurers see signs of life in Q1

Activist Glenview cuts stake in CVS after strong first-quarter earnings

Glenview Capital Issues Statement on CVS Health

HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down

INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts

What Makes CVS Health (CVS) a New Buy Stock

Eli Lilly Stock Slips on Outlook. Is It Time to Buy the Dip?

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?

CVS Health Corporation (CVS): Among the Best Performing Large Cap Stocks So Far in 2025

With compounders out of the way, Lilly and Novo go after each other

Performance Overview